Currently, hyaluronate injections are approved for the treatment of osteoarthritis of the knee in those who have failed to respond to more conservative therapy. Use for other joints is being investigated.
Currently, there are five FDA appoved hyaluronates:
Fast Facts About Viscosupplementation:
- Viscosupplementation has been studied for osteoarthritis treatment since the 1970s.
- Hyalgan injections were FDA approved on 05/28/1997.
- Synvisc injections were FDA approved on 08/08/1997.
- Supartz injections were FDA approved on 01/24/2001.
- Orthovisc injections were FDA approved on 02/05/2004.
- Euflexxa injections were FDA approved on 12/03/2004.
- Hyaluronates are considered treatments or therapies, not drugs.
What is Viscosupplementation?, The Cleveland Clinic Department of Patient Education and Health Information, 12/17/2003
Viscosupplementation Treatment for Arthritis, American Academy of Orthopaedic Surgeons, November 2000
What Is Viscosupplementation?, synvisc.com